Quetiapine 25 / 100 / 200 / 300 Unicorn 25mg / 100mg / 200mg / 300mg FC tablets
PDF Leaflet Revision Date: May 2024
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of schizophrenia and manic episodes associated with bipolar disorder.
Dosage (summary)
Adults: Start with 25 mg/day, titrate to 300-450 mg/day for schizophrenia; 100 mg/day, titrate to 400-800 mg/day for bipolar mania.
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Contraindicated in pregnancy; breastfeeding not recommended.
Key Drug Interactions
- CYP3A4 inhibitors
- CNS depressants
- Antihypertensives
Contraindications
- Hypersensitivity
- Pregnancy and lactation
- Severe liver and renal impairment
Common side effects
- Somnolence
- Dizziness
- Weight gain
- Hyperglycaemia
Counselling Points
- Monitor for suicidal ideation
- Regular metabolic assessments
- Avoid abrupt discontinuation
Serious warnings
- Risk of suicidal thoughts
- Metabolic syndrome
- QT prolongation
Important Disclaimer
The Quetiapine 25 / 100 / 200 / 300 Unicorn 25mg / 100mg / 200mg / 300mg FC tablets professional information leaflet below is the property of Unicorn Pharmaceuticals and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
